Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma

Melody B Oncale, Hossein Maymani, Loretta J Nastoupil Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Abstract: Immunotherapy is a rapidly evolving therapeutic option in the treatment of lymphoma....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Oncale MB, Maymani H, Nastoupil LJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/0ba68679533d455ca73fb5c9cf5a71ab
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!